Overview on fosfomycin and its current and future clinical significance
Fosfomycin is an old antibiotic with a unique chemical structure and with broadspectrum activity against numerous bacterial pathogens, both Gram-positive and Gramnegative, including resistant and multi-resistant strains. This antibiotic was accepted into
Beata Chudzik-Rzad +4 more
core +1 more source
Antibacterial prophylaxis in neutropenic fever: beyond fluoroquinolones. [PDF]
Douglas AP, Thursky KA.
europepmc +1 more source
Stabilität von Fosfomycin in Peritonealdialyselösungen
Peritonealdialyse ist eine spezielle Form der Dialyse, bei der das Peritoneum als Dialysemembran verwendet wird. Dazu wird die Peritonealdialyselösung in den Bauch-raum eingeleitet, wo die zu entgiftenden Substanzen aus dem Blut der Kapillaren des ...
Baumann, Alexandra
core
First Randomized Controlled Trial Comparing D-Mannose to Fosfomycin in Acute Uncomplicated Lower Urinary Tract Infections. [PDF]
Wagenlehner F +6 more
europepmc +1 more source
Comparative Effectiveness of Empiric Antibiotics for Uncomplicated Urinary Tract Infection in Postmenopausal Women. [PDF]
Lacsamana JM +5 more
europepmc +1 more source
Fosfomycin Trometamol in the Management of Urinary Tract Infection: A Focus on Antimicrobial Susceptibility and Resistance. [PDF]
Stefani S, Tascini C.
europepmc +1 more source
Fosfomycin Resistance Dynamics in Major Uropathogens: A 2013-2025 Integrated Disease Surveillance of Multidrug-Resistant, Extended-Spectrum Beta-Lactamase-Producing, Non-Extended-Spectrum Beta-Lactamase, and Enterococcal Urinary Isolates. [PDF]
Saeed U +8 more
europepmc +1 more source
Fosfomycin Resistance in Escherichia coli: Mechanisms, Trends, and Clinical Challenges. [PDF]
Patkar GN, Mane PM, Patil SR.
europepmc +1 more source
Intravenous fosfomycin-containing regimens are associated with reduced acute kidney injury in carbapenem-resistant Gram-negative infections: a retrospective cohort study. [PDF]
D'Avino A +7 more
europepmc +1 more source
Nitrofurantoin treatment and prophylaxis for recurrent urinary tract infections in women: First-line for a reason. [PDF]
Szlachta-McGinn A, Ackerman AL.
europepmc +1 more source

